1. Market Research
  2. > Pharmaceutical Market Trends
Pharmaceuticals Industry in India 2015-2020

Pharmaceuticals Industry in India 2015-2020

  • August 2015
  • 298 pages
  • ID: 3812876
  • Format: PDF
  • NAVADHI Market Research

Summary

Table of Contents

Pharmaceuticals Industry in India is expected to be worth US$ 55.39 billion by 2020. Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases.

The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers.

The generics portfolio dominates the Indian Pharma Industry which accounts for over 70% of the market. The Indian Pharma market is largely fragmented. With a string of Mergers and Acquisitions within the market in the last decade, consolidation of the overall market has been the key Industry feature.

India’s Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.

As per NOVONOUS estimates, pharmaceuticals manufacturing industry in India is expected to grow at a CAGR of 19.76% till 2020. Despite slowing growth in developed markets, players in generics are expected to perform reasonably well due to significant numbers of exclusivity losses and patent expirations on leading drugs in the upcoming years.

Medical devices manufacturing industry in India is expected to grow at a CAGR of 15% till 2020. Indian Medical Devices and Equipment industry is an import-led market and about 70%-80% of finished goods and related components are sourced from foreign countries. This trend is expected to continue till 2020.

Indian medical transcription Industry is expected to grow at a CAGR of 4.16% till 2020 found this study. The Pharma service predominantly includes Medical Transcription, Telemedicine, Clinical Trials, Clinical Data Management and Teleradiology amongst the others.

Private sector telemedicine industry in India is expected to grow at a CAGR of 12.35% till 2020.

On the other hand, Pharmaceuticals packaging industry in India is expected to grow at a CAGR of 5.46% till 2020.

NOVONOUS estimates that pharmaceuticals retail industry in India will grow at a CAGR of 5% in the next 5 years, which will be mainly driven by increased penetration of organized Pharma retail chains like Apollo Pharmacy, MedPlus etc.

The report also has detailed company profiles including their position in pharmaceuticals industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for sixteen key players in Indian market namely Abbott India, Biocon Limited, CIPLA Limited, Dr. Reddy’s Laboratories, Sun Pharmaceuticals Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Divis Laboratories Limited, IPCA Laboratories Limited, Becton Dickinson & Company Limited, Poly Medicure Limited, Novartis India Limited, Apollo Pharmacy, MedPlus Health Services Pvt. Ltd. and National Institute of Pharmaceutical Education and Research (NIPER).

Scope of Pharmaceuticals Industry in India 2015 - 2020 report:
- This report provides a detailed view of Indian pharmaceuticals market with current available capacity and options.
- This report identifies the need for focusing on pharmaceuticals sector in India.
- This report provides detailed information on growth forecasts for overall pharmaceuticals industry in India up to 2020.
- This report provides detailed information on growth forecasts for pharmaceuticals manufacturing industry in India up to 2020.
- This report provides detailed information on growth forecasts for pharma services industry in India up to 2020.
- This report provides detailed information on growth forecasts for pharmaceuticals packaging industry in India up to 2020.
- This report provides detailed information on growth forecasts for pharmaceuticals retail industry in India up to 2020.
- The report identifies the growth drivers and inhibitors for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
- This study also identifies policies related to pharmaceuticals market in India for various sectors.
- The report identifies various credit, policy and technical risks associated with pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging, pharmaceuticals retail, and pharmaceuticals R&D industry in India.
- The report identifies EXIM scenario for pharmaceuticals products and medical devices market in India.
- The report identifies top countries exporting pharmaceuticals products and medical devices to India.
- The report identifies top countries importing pharmaceuticals products and medical devices from India.
- This report has detailed profiles 16 key players in Indian pharmaceuticals market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
- This report covers in details the competitive landscape in Indian pharmaceuticals market.
- This report identifies key industry bodies and associations and their role in Indian pharmaceuticals market.
- This report identifies key government bodies and their role in Indian pharmaceuticals market.
- This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals market.
- This report provides Porter's Five Forces analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
- This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
- This report provides future trends and opportunities for pharmaceuticals market in India.
- This report also provides strategic recommendations for policy makers, pharmaceuticals manufacturers and end users.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Genito-Urinary Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • $ 4000
  • February 2021
  • 300 pages

Major companies in the genito-urinary drugs market include Daiichi Sankyo Company; Pfizer Inc; Bayer AG; Astellas Pharma Inc and Allergan Plc. The global genito-urinary drugs market is expected to grow ...

  • World
  • Pharmaceutical
  • Incontinence Product
  • Industry analysis
  • Health Expenditure
  • Population Over Age Of 65

ref:plp2015

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on